{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:43:31Z","timestamp":1791575011887,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Brucellosis is a worldwide zoonotic disease that causes serious public health problems. This study aimed to identify <jats:italic>Brucella<\/jats:italic> strains isolated from various clinical samples by conventional and molecular methods and to determine antimicrobial susceptibilities against doxycycline (DOX), streptomycin (STR), ciprofloxacin (CIP) and rifampicin (RIF) by the gradient strip (<jats:italic>E<\/jats:italic> test) test method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 87 <jats:italic>Brucella<\/jats:italic> strains isolated from various clinical specimens between 2004 and 2018 were included in this study. While four of the 87 strains included in the study were identified only at the genus level, the remaining 83 strains were identified at the species level by the Real-Time Multiplex PCR <jats:bold>(<\/jats:bold>M-RT-PCR) method and conventional methods were used for biotyping.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>According to molecular identification results, 83 strains were identified as <jats:italic>B. melitensis<\/jats:italic> by the M-RT-PCR method, with 82 strains identified as <jats:italic>Brucella melitensis<\/jats:italic> biovar (bv) 3 and one as <jats:italic>B. melitensis<\/jats:italic> bv 1 according to the conventional biotyping method. Among the antibiotics studied, CIP was found to be the most active agent according to the minimum inhibitory concentrations (MIC)<jats:sub>90<\/jats:sub> values. This was followed by DOX and STR, respectively. While all of the isolates were sensitive to CIP, DOX and STR, 18 (20.7%) strains were found to be moderately susceptible to RIF, with the highest values of MIC<jats:sub>50<\/jats:sub> and MIC<jats:sub>90<\/jats:sub>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In our study, all strains were identified as <jats:italic>B. melitensis<\/jats:italic>. DOX, STR, CIP and RIF used in the treatment of brucellosis were found to be effective.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-021-00527-5","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T10:02:57Z","timestamp":1623837777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Investigation of antibiotic susceptibilities of Brucella Strains isolated from various clinical samples in eastern Turkey"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8457-3564","authenticated-orcid":false,"given":"Esra","family":"G\u00fcltekin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet Hamidullah","family":"Uyan\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sel\u00e7uk","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"527_CR1","volume-title":"Brucellosis in humans and animals","author":"MJ Corbel","year":"2006","unstructured":"Corbel MJ. Brucellosis in humans and animals. Geneva: World Health Organization; 2006."},{"issue":"1","key":"527_CR2","first-page":"1","volume":"6","author":"P Etiz","year":"2015","unstructured":"Etiz P, Kibar F, Ekenoglu Y, Yaman A. Characterization of antibiotic susceptibility of Brucella spp. isolates with E-test method. ACM. 2015;6(1):1\u20135.","journal-title":"ACM"},{"key":"527_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/596245","author":"R Hashim","year":"2014","unstructured":"Hashim R, Ahmad N, Mohamed Zahidi J, Tay BY, Mohd Noor A, Zainal S, et al. Identification and in vitro antimicrobial susceptibility of Brucella species isolated from human brucellosis. Int J Microbiol. 2014. https:\/\/doi.org\/10.1155\/2014\/596245.","journal-title":"Int J Microbiol"},{"issue":"3","key":"527_CR4","first-page":"392","volume":"45","author":"A \u00c7erekci","year":"2011","unstructured":"\u00c7erekci A, K\u0131l\u0131\u00e7 S, Bayraktar M, Uyan\u0131k MH, Ya\u015far E, Esen B. Comparison of conventional methods and real-time multiplex polymerase chain reaction for identification and typing of Brucella isolates of human origin. Mikrobiyol Bul. 2011;45(3):392\u2013400.","journal-title":"Mikrobiyol Bul"},{"issue":"4","key":"527_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5222\/TMCD.2012.142","volume":"42","author":"E G\u00fcltek\u0131\u0307n","year":"2012","unstructured":"G\u00fcltek\u0131\u0307n E, Uyan\u0131k MH, Albayrak A, Aksoy O, Ayy\u0131ld\u0131z A. Bruselloz tan\u0131s\u0131nda kullan\u0131lan \u00e7e\u015fitli serolojik y\u00f6ntemlerin kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131. T\u00fcrk Mikrobiyol Cem Derg. 2012;42(4):142\u20137.","journal-title":"T\u00fcrk Mikrobiyol Cem Derg"},{"issue":"2","key":"527_CR6","first-page":"103","volume":"17","author":"H \u015eim\u015fek","year":"2004","unstructured":"\u015eim\u015fek H, Erdenli\u011f S, Oral B, T\u00fclek N. Typing-biotyping of Brucella isolates of human origin and their epidemiologic evaluation. Klimik Derg. 2004;17(2):103\u20136.","journal-title":"Klimik Derg"},{"key":"527_CR7","unstructured":"Joint FAO\/WHO expert committee on brucellosis. World Health Organ Tech Rep Ser. 1986;740:1\u2013132."},{"key":"527_CR8","series-title":"Monograph Series","first-page":"1","volume-title":"Laboratory techniques in brucellosis","author":"GG Alton","year":"1975","unstructured":"Alton GG, Jones LM, Pietz DE. Laboratory techniques in brucellosis, vol. 55. Monograph Series. Geneva: World Health Organ; 1975. p. 1\u2013163."},{"key":"527_CR9","volume-title":"Performance standards for antimicrobial susceptibility testing. 20: M 100-S20","author":"Clinical and Laboratory Standards Institute","year":"2010","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 20: M 100-S20. Wayne: CLSI; 2010."},{"key":"527_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3109\/00365548.2014.988748","volume":"47","author":"A Denk","year":"2015","unstructured":"Denk A, Dem\u0131rdag K, Kalkan A, Ozden M, Cet\u0131nkaya B, K\u0131l\u0131c SS. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey. Infect Dis. 2015;47:364\u20139.","journal-title":"Infect Dis"},{"key":"527_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ijantimicag.2003.09.024","volume":"23","author":"N Baykam","year":"2004","unstructured":"Baykam N, Esener H, Erg\u00f6n\u00fcl \u00d6, Eren \u015e, Celikba\u015f AK, Dokuzo\u011fuz B. In vitro antimicrobial susceptibility of Brucella species. Int J Antimicrob Agents. 2004;23:405\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"527_CR12","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.7150\/ijms.6565","volume":"10","author":"M Parlak","year":"2013","unstructured":"Parlak M, G\u00fcd\u00fcc\u00fco\u011flu H, Bayram Y, \u00c7\u0131kman A, Aypak C, K\u0131l\u0131\u00e7 S, et al. Identification and determination of antibiotic susceptibilities of Brucella strains isolated from patients in Van, Turkey by conventional and molecular methods. Int J Med Sci. 2013;10:1406\u201311.","journal-title":"Int J Med Sci"},{"issue":"9","key":"527_CR13","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1128\/JCM.02538-10","volume":"49","author":"S K\u0131l\u0131\u00e7","year":"2011","unstructured":"K\u0131l\u0131\u00e7 S, Ivanov IN, Durmaz R, Bayraktar MR, Aya\u015fl\u0131o\u011flu E, Uyan\u0131k MH, et al. Multiple-locus variable-number tandem-repeat analysis genotyping of human Brucella isolates from Turkey. JCM. 2011;49(9):3276\u201383.","journal-title":"JCM"},{"key":"527_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-0711-11-24","volume":"11","author":"M Abdel-Maksoud","year":"2012","unstructured":"Abdel-Maksoud M, House B, Wasfy M, Abdel-Rahman B, Pimentel G, Roushdy G, et al. In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance. Ann Clin Microbiol Antimicrob. 2012;11:24.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"9","key":"527_CR15","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1128\/JCM.00822-07","volume":"45","author":"C Marianelli","year":"2007","unstructured":"Marianelli C, Graziani C, Santangelo C, Xibilia MT, Imbriani A, Amato R, et al. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy. J Clin Microbiol. 2007;45(9):2923\u201338.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"527_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.7150\/ijms.8.198","volume":"8","author":"Y Bayram","year":"2011","unstructured":"Bayram Y, Korkoca H, Aypak C, Parlak M, \u00c7\u0131kman A, Kilic S, et al. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens. Int J Med Sci. 2011;8(3):198\u2013202.","journal-title":"Int J Med Sci"},{"key":"527_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/00365540310008348","volume":"35","author":"H Bodur","year":"2003","unstructured":"Bodur H, Balaban N, Aksaray S, Yetener V, Ak\u0131nc\u0131 E, \u00c7olpan A, et al. Biotypes and antimicrobial susceptibilities of Brucella isolates. Scand J Infect Dis. 2003;35:337\u20138.","journal-title":"Scand J Infect Dis"},{"key":"527_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1590\/S1517-83822008000200006","volume":"39","author":"S K\u0131l\u0131\u00e7","year":"2008","unstructured":"K\u0131l\u0131\u00e7 S, Dizbay M, Hizel K, Arman D. In vitro synergistic activity of antibiotic combinations against Brucella melitensis using E-test methodology. Braz J Microbiol. 2008;39:233\u20137.","journal-title":"Braz J Microbiol"},{"key":"527_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000088122","volume":"14","author":"T Yamazhan","year":"2005","unstructured":"Yamazhan T, Aydemir \u015e, T\u00fcnger A, Serter D, G\u00f6kengin D. In vitro activities of various antimicrobials against Brucella melitensis strains in the aegean region in Turkey. Med Princ Pract. 2005;14:413\u20136.","journal-title":"Med Princ Pract"},{"issue":"1","key":"527_CR20","first-page":"145","volume":"42","author":"O Kaya","year":"2012","unstructured":"Kaya O, Ak\u00e7am FZ, Yayl\u0131 G. Investigation of the in vitro activities of various antibiotics against Brucella melitensis strains. Turk J Med Sci. 2012;42(1):145\u20138.","journal-title":"Turk J Med Sci"},{"key":"527_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10156-011-0281-7","volume":"18","author":"M Sayan","year":"2012","unstructured":"Sayan M, K\u0131l\u0131c S, Uyan\u0131k MH. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey. J Infect Chemother. 2012;18:41\u20136.","journal-title":"J Infect Chemother"},{"key":"527_CR22","volume-title":"Performance standards for antimicrobial susceptibility testing. 26: M 100-S16","author":"Clinical and Laboratory Standards Institute","year":"2006","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 26: M 100-S16. CLSI: Wayne; 2006."},{"key":"527_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12866-015-0458-9","volume":"15","author":"A Deshmukh","year":"2015","unstructured":"Deshmukh A, Hagen F, Sharabasi OA, Abraham M, Wilson G, Doiphode S, et al. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014\u20132015. BMC Microbiol. 2015;15:121.","journal-title":"BMC Microbiol"},{"key":"527_CR24","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0; 2021. http:\/\/www.eucast.org."},{"key":"527_CR25","first-page":"625","volume-title":"Manual of clinical microbiology","author":"DS Shapiro","year":"1999","unstructured":"Shapiro DS, Wong JD. Brucella. In: Murray BE, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. Washington DC: ASM Press; 1999. p. 625\u201331."},{"key":"527_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S1995-7645(13)60165-0","volume":"6","author":"XL Xu","year":"2013","unstructured":"Xu XL, Chen X, Yang PH, Liu JY, Hao XK. In vitro drug resistance of clinical isolated Brucella against antimicrobial agents. Asian Pac J Trop Med. 2013;6:921\u20134.","journal-title":"Asian Pac J Trop Med"},{"issue":"3","key":"527_CR27","first-page":"261","volume":"26","author":"B Altun","year":"2009","unstructured":"Altun B, Has\u00e7elik G, G\u00fcr D. In vitro activity of tigecycline against Brucella spp. Med J Trakya Univ. 2009;26(3):261\u20133.","journal-title":"Med J Trakya Univ"},{"key":"527_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-0711-5-24","volume":"5","author":"A Turkmani","year":"2006","unstructured":"Turkmani A, Ioannidis A, Christidou A, Psaroulaki A, Loukaides F, Tselentis Y. In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics. Ann Clin Microbiol Antimicrob. 2006;5:24.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"527_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.33073\/pjm-2010-008","volume":"59","author":"B Ozhak-Baysan","year":"2010","unstructured":"Ozhak-Baysan B, Ongut G, Ogunc D, Gunseren F, Sepin-Ozen N, Ozturk F, et al. Evaluation of in vitro activities of tigecycline and various antibiotics against Brucella spp. Pol J Microbiol. 2010;59(1):55\u201360.","journal-title":"Pol J Microbiol"},{"issue":"3","key":"527_CR30","first-page":"257","volume":"38","author":"E Aya\u015fl\u0131o\u011flu","year":"2008","unstructured":"Aya\u015fl\u0131o\u011flu E, K\u0131l\u0131\u00e7 S, Ayd\u0131n K, K\u0131l\u0131\u00e7 D, Kaygusuz S, A\u011falar C. Antimicrobial susceptibility of Brucella melitensis isolates from blood samples. Turk J Med Sci. 2008;38(3):257\u201362.","journal-title":"Turk J Med Sci"},{"issue":"3","key":"527_CR31","first-page":"147","volume":"21","author":"H Turan","year":"2007","unstructured":"Turan H, Arslan H, Uncu H, Azap \u00d6, \u015eerefhano\u011flu K. In vitro activity of tigecycline against Brucella strains: a comparative study with doxycycline, ciprofloxacin and rifampin. Turk J Infect. 2007;21(3):147\u201351.","journal-title":"Turk J Infect"},{"issue":"4","key":"527_CR32","first-page":"196","volume":"18","author":"D E\u015fel","year":"2004","unstructured":"E\u015fel D, S\u00fcmerkan B, Ayangil D, Telli M. Brucella melitensis su\u015flar\u0131n\u0131n antibiyotik duyarliliklarinin belirlenmesinde agar dil\u00fcsyon ve E-test y\u00f6ntemlerinin kar\u015fila\u015ftirilmasi. ANKEM Derg. 2004;18(4):196\u20139.","journal-title":"ANKEM Derg"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-021-00527-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-021-00527-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-021-00527-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T10:04:15Z","timestamp":1623837855000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-021-00527-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1186\/s40001-021-00527-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"11 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}